CodeSystem Comparison between http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution vs http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution

Messages

InformationCodeSystem.copyrightValues for copyright differ: 'This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html' vs 'This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license'
InformationCodeSystem.concept.where(code='_ActSubstanceAdminSubstitutionCode').definitionChanged value for definition: 'Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.' vs '**Description:** Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.'
InformationCodeSystem.concept.where(code='_ActSubstanceAdminSubstitutionCode').concept.where(code='E').definitionChanged value for definition: 'Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.' vs '**Description:** Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.'
InformationCodeSystem.concept.where(code='_ActSubstanceAdminSubstitutionCode').concept.where(code='E').concept.where(code='EC').definitionChanged value for definition: 'Substitution occurred or is permitted with another product that is a: * pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester * pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration *Examples:* * *Pharmaceutical alternative:* Erythromycin Ethylsuccinate for Erythromycin Stearate * *Pharmaceutical equivalent:* Lisonpril for Zestril' vs '**Description:** Substitution occurred or is permitted with another product that is a: * pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester * pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration *Examples:* * *Pharmaceutical alternative:* Erythromycin Ethylsuccinate for Erythromycin Stearate * *Pharmaceutical equivalent:* Lisonpril for Zestril'
InformationCodeSystem.concept.where(code='_ActSubstanceAdminSubstitutionCode').concept.where(code='E').concept.where(code='EC').concept.where(code='BC').definitionChanged value for definition: 'Substitution occurred or is permitted between equivalent Brands but not Generics *Examples:* * Zestril for Prinivil * Coumadin for Jantoven' vs '**Description:** Substitution occurred or is permitted between equivalent Brands but not Generics *Examples:* * Zestril for Prinivil * Coumadin for Jantoven'
InformationCodeSystem.concept.where(code='_ActSubstanceAdminSubstitutionCode').concept.where(code='E').concept.where(code='EC').concept.where(code='G').definitionChanged value for definition: 'Substitution occurred or is permitted between equivalent Generics but not Brands *Examples:* * Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)' vs '**Description:** Substitution occurred or is permitted between equivalent Generics but not Brands *Examples:* * Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)'
InformationCodeSystem.concept.where(code='_ActSubstanceAdminSubstitutionCode').concept.where(code='E').concept.where(code='TE').definitionChanged value for definition: 'Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. *Examples:* * ranitidine for Tagamet' vs '**Description:** Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. *Examples:* * ranitidine for Tagamet'
InformationCodeSystem.concept.where(code='_ActSubstanceAdminSubstitutionCode').concept.where(code='E').concept.where(code='TE').concept.where(code='TB').definitionChanged value for definition: 'Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics > *Examples:* * Zantac for Tagamet' vs '**Description:** Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics > *Examples:* * Zantac for Tagamet'
InformationCodeSystem.concept.where(code='_ActSubstanceAdminSubstitutionCode').concept.where(code='E').concept.where(code='TE').concept.where(code='TG').definitionChanged value for definition: 'Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands > *Examples:* * Ranitidine for cimetidine' vs '**Description:** Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands > *Examples:* * Ranitidine for cimetidine'
InformationCodeSystem.concept.where(code='_ActSubstanceAdminSubstitutionCode').concept.where(code='F').definitionChanged value for definition: 'This substitution was performed or is permitted based on formulary guidelines.' vs '**Description:** This substitution was performed or is permitted based on formulary guidelines.'

Metadata

NameValueComments
.caseSensitivetrue
    .compositional
      .contentcomplete
        .copyrightThis material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.htmlThis material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license
        • Values Differ
        .date2019-03-20
          .descriptionIdentifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.
            .experimentalfalse
              .hierarchyMeaningis-a
                .jurisdiction
                  .nameSubstanceAdminSubstitution
                    .publisherHealth Level Seven International
                      .purpose
                        .statusactive
                          .titleSubstance Admin Substitution
                            .urlhttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution
                              .version3.0.0
                                .versionNeeded

                                  Concepts

                                  CodeDisplaySpecializesGeneralizesinternalIdnotSelectablestatusSpecializesGeneralizesinternalIdnotSelectablestatusComments
                                  ._ActSubstanceAdminSubstitutionCodeActSubstanceAdminSubstitutionCode2128421284BooleanType[true]BooleanType[true]activeactive2128421284BooleanType[true]BooleanType[true]activeactive
                                  • definition changed from left to right